Gerresheimer (ETR:GXI) has been given a €70.00 ($81.40) price objective by analysts at Commerzbank in a research note issued to investors on Thursday. The firm currently has a “neutral” rating on the stock. Commerzbank’s price target indicates a potential upside of 13.82% from the stock’s current price.
Several other brokerages have also recently issued reports on GXI. JPMorgan Chase & Co. set a €72.00 ($83.72) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Tuesday. Deutsche Bank reissued a “buy” rating on shares of Gerresheimer in a report on Friday, September 21st. Credit Suisse Group set a €88.00 ($102.33) price objective on Gerresheimer and gave the company a “buy” rating in a report on Monday, September 17th. equinet set a €69.00 ($80.23) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Monday, September 24th. Finally, HSBC set a €65.00 ($75.58) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Tuesday, October 2nd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of €71.67 ($83.33).
Gerresheimer stock opened at €61.50 ($71.51) on Thursday. Gerresheimer has a fifty-two week low of €59.97 ($69.73) and a fifty-two week high of €78.25 ($90.99).
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Further Reading: What are the reasons investors use put options?
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.